AMBER BECK: Open Payments
NPI 1174004675 · DU BOIS, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$578 in 32 payments from 10 companies in 2025. Trend: 2023 $504 · 2024 $650 · 2025 $578
Food & beverage: $569Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $176 |
| LEO Pharma Inc. | 4 | $115 |
| Organon LLC | 4 | $64 |
| Janssen Biotech, Inc. | 3 | $49 |
| Novartis Pharmaceuticals Corporation | 2 | $45 |
| Amgen Inc. | 2 | $33 |
| Regeneron Healthcare Solutions, Inc. | 1 | $30 |
| UCB, Inc. | 1 | $28 |
| Lilly USA, LLC | 1 | $22 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
Products named: ADBRY, SKYRIZI, CREON, TREMFYA, OTEZLA, DUPIXENT, Bimzelx, COSENTYX.
Industry payments across PA — which companies pay providers there.
